
Stay Updated with the Latest Vanguard Short-Term Federal Fund Investor Shares VSGBX News in Real Time
Find VSGBX news now at Meyka AI. Stay informed with the latest Vanguard Short-Term Federal Fund Investor Shares stocks updates, including price news, market analysis, and expert insights.

Gaja Alternative IPO GMP Today: How Gaja Capital Is Challenging the AIF Model
Gaja Alternative IPO’s Grey Market Premium stood at ₹21 as of Thursday, August 20, 2026, 9:45 AM IST. That implies a listing price near ₹181, a 13% premium over the ₹160 upper band. The ₹550 crore issue from Gaja Capital’s asset management arm closes for subscription on August 21. Overall subscription remained modest at 0.30…

Crypto Tax Warning: HMRC Sent More Than 81,000 Letters to Cryptocurrency Holders
HMRC has stepped up its focus on cryptocurrency taxes, with more than 81,000 warning letters reportedly sent to UK crypto holders during the 2025-26 tax year. The move comes as new crypto reporting rules take effect from January 1, 2026, giving HMRC greater access to user and transaction data. For investors, the message is clear:…

Social Security COLA 2027: New 3.6% Estimate Shows a Smaller Raise for Retirees
The Social Security COLA for 2027 now stands at an estimated 3.6%, according to The Senior Citizens League. That’s down from 3.8% forecasts published in June and July. The drop follows July’s Consumer Price Index report, which showed inflation cooling to 3.4% year-over-year. Retirees would still see the largest benefit bump in four years if…

Moderna Soars 177% After Melanoma Vaccine Clears Phase 3 Trial on August 20
Moderna stock jumped 177% after its melanoma vaccine met Phase 3 trial endpoints. The personalized mRNA therapy showed significant improvements over standard treatment in over 1,100 patients.

Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.

Aldi Worker Ordered to Pay $1,230 After AI-Generated Unfair Dismissal Claim Fails
Sydney Aldi worker ordered to pay $1,230 in legal costs after Fair Work rejected his AI-generated unfair dismissal claim. He was dismissed three days short of the six-month eligibility threshold.

xAI Founder Tony Yuhuai Wu Buys Rs 670 Crore California Mansion After 6 Years in AI
xAI co-founder Tony Yuhuai Wu reportedly buys Rs 670 crore Villa de Verano mansion in California with nine-hole golf course and 150-seat amphitheatre after six years in AI.

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12%
Moderna jumped 177% and Merck rose 12% after announcing the first Phase 3 win for an mRNA cancer vaccine. The personalized treatment reduced melanoma recurrence risk significantly.

Alibaba Sells Lingxi Games for $1.5B, Pivots to AI on August 20
Alibaba sells gaming unit Lingxi Games to Trustar Capital for USD 1.5 billion, redirecting capital to AI and cloud infrastructure as part of CEO Wu Yongming’s business restructuring.